Publication: SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021).
Loading...
Identifiers
Date
2022-02-22
Authors
Capdevila, Jaume
Gomez, Ma Auxiliadora
Guillot, Monica
Paez, David
Pericay, Carles
Safont, Maria Jose
Tarazona, Noelia
Vera, Ruth
Vidal, Joana
Sastre, Javier
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Springer
Abstract
The management of localized rectal cancer requires a multidisciplinary approach to optimize outcomes, reduce morbidity and prevent under or overtreatments. While early stages may obtain benefit of local resections without any additional therapies, locally advanced rectal cancer becomes a challenge defining the better sequential strategy of surgery, radiotherapy and chemotherapy. The latest results of international phase III studies have positioned the total neoadjuvant therapy as a potential new standard of care in high risk rectal cancers, however, the best schedule is still not well defined.
Description
MeSH Terms
Antineoplastic combined chemotherapy protocols
Chemoradiotherapy
Humans
Neoadjuvant therapy
Neoplasm staging
Neoplasms, second primary
Rectal neoplasms
Rectum
Chemoradiotherapy
Humans
Neoadjuvant therapy
Neoplasm staging
Neoplasms, second primary
Rectal neoplasms
Rectum
DeCS Terms
Estadificación de neoplasias
Neoplasias primarias secundarias
Neoplasias del recto
Protocolos de quimioterapia combinada antineoplásica
Quimioradioterapia
Recto
Terapia neoadyuvante
Neoplasias primarias secundarias
Neoplasias del recto
Protocolos de quimioterapia combinada antineoplásica
Quimioradioterapia
Recto
Terapia neoadyuvante
CIE Terms
Keywords
Guideline, Rectal cancer, Total neoadjuvant therapy
Citation
Capdevila J, Gómez MA, Guillot M, Páez D, Pericay C, Safont MJ, et al. SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021). Clin Transl Oncol. 2022 Apr;24(4):646-657. doi: 10.1007/s12094-022-02816-9. Epub 2022 Mar 18. Erratum in: Clin Transl Oncol. 2022 Jul;24(7):1443-1444